These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1794360)

  • 1. Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
    Just-Nübling G; Gentschew G; Meissner K; Odewald J; Staszewski S; Helm EB; Stille W
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):917-21. PubMed ID: 1794360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
    Thorsen S; Mathiesen LR
    Scand J Infect Dis; 1990; 22(3):375-6. PubMed ID: 2371551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
    Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Greenspan D
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S51-5. PubMed ID: 7915732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
    Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    Hernández-Sampelayo T
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis.
    Diz Dios PD; Alvarez Alvarez J; Fernández Feijoo J; Castro Ferreiro M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Feb; 79(2):170-4. PubMed ID: 7614179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole resistant oral candidiasis in HIV-infected patients.
    Tumbarello M; Tacconelli E; Caldarola G; Morace G; Cauda R; Ortona L
    Oral Dis; 1997 May; 3 Suppl 1():S110-2. PubMed ID: 9456668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans resistance in AIDS.
    Kitchen VS; Savage M; Harris JR
    J Infect; 1991 Mar; 22(2):204-5. PubMed ID: 2026898
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
    Lim SG; Lee CA; Hales M; O'Doherty M; Winter M; Kernoff PB
    Aliment Pharmacol Ther; 1991 Apr; 5(2):199-205. PubMed ID: 1888820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
    Barchiesi F; Giacometti A; Arzeni D; Branchesi P; Crescenzi G; Ancarani F; Scalise G
    J Chemother; 1992 Dec; 4(6):381-6. PubMed ID: 1287140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
    De Wit S; Weerts D; Goossens H; Clumeck N
    Lancet; 1989 Apr; 1(8641):746-8. PubMed ID: 2564563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.
    Meunier F; Aoun M; Gerard M
    Rev Infect Dis; 1990; 12 Suppl 3():S364-8. PubMed ID: 2184513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory oral candidiasis with fluconazole. A case report.
    Lucatorto FM; Franker C; Hardy WD; Chafey S
    Oral Surg Oral Med Oral Pathol; 1991 Jan; 71(1):42-4. PubMed ID: 1994321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
    Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
    Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group.
    Pons V; Greenspan D; Debruin M
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1311-6. PubMed ID: 8254467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.